Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Phase III trial of an alpha-pharmaceutical

Dr Chris Parker - The Royal Marsden Cancer Centre, London, UK

Phase III trial of an alpha-pharmaceutical ( Dr Chris Parker - The Royal Marsden Cancer Centre, London, UK )

Chemotherapy infusions directly to organs

Prof James Pingpank - University of Pittsburgh School of Medicine, USA

Chemotherapy infusions directly to organs ( Prof James Pingpank - University of Pittsburgh School of Medicine, USA )

ecancerhub past, present and future

Prof Richard Sullivan - King's College London, UK

ecancerhub past, present and future ( Prof Richard Sullivan - King's College London, UK )

Early detection and prevention of melanoma (6/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Early detection and prevention of melanoma (6/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Guidelines and recommendations for advanced melanoma (5/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Guidelines and recommendations for advanced melanoma (5/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Combination of newer agents in advanced melanoma (4/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Combination of newer agents in advanced melanoma (4/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Recent advances in advanced melanoma: BRAF inhibitors (3/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Recent advances in advanced melanoma: BRAF inhibitors (3/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Recent advances in advanced melanoma: ipilimumab (2/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Recent advances in advanced melanoma: ipilimumab (2/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Metastatic melanoma: changes in epidemiology and current standards of care (1/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Metastatic melanoma: changes in epidemiology and current standards of care (1/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Personalised medicine and cancer control in India

Dr Rita Mulherkar - Tata Memorial Centre, Mumbai, India

Personalised medicine and cancer control in India ( Dr Rita Mulherkar - Tata Memorial Centre, Mumbai, India )

Development of personalised medicine from animal testing

Prof Soo Khee Chee – National Cancer Centre, Singapore

Development of personalised medicine from animal testing ( Prof Soo Khee Chee – National Cancer Centre, Singapore )

Importance and impact of the WIN Symposium

Prof Alexander Eggermont – Gustave Roussy Cancer Institute, Paris, France

Importance and impact of the WIN Symposium ( Prof Alexander Eggermont – Gustave Roussy Cancer Institute, Paris, France )

More from ecancer